A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria.
Mutations of the flavin-containing monooxygenase type 3 gene (FMO3) that encode the major functional form present in adult human liver, have been shown to cause trimethylaminuria. We now report a novel homozygous deletion of exons 1 and 2 in an Australian of Greek ancestry with TMAuria, the first report of a deletion causative of trimethylaminuria. The deletion occurs 328 bp upstream from exon 1. The 3'-end of the deletion occurs in intron 2, 10013 base pairs downstream from the end of exon 2. The deletion is 12226 bp long. For the proband homozygous for the human FMO3 gene deletion, it is predicted that in addition to loss of monooxygenase function for human FMO3 substrates, such as TMA and other amines, the proband will exhibit decreased tolerance of biogenic amines, both medicinal and those found in foods.
Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia. forrest@cryptic.rch.unimelb.edu.au
S M
SM
Forrest
M
M
Knight
B R
BR
Akerman
J R
JR
Cashman
E P
EP
Treacy
D000293:Adolescent; D001483:Base Sequence; D015139:Blotting, Southern; D017931:DNA Primers; D005091:Exons; D017353:Gene Deletion; D006115:Greece; D006720:Homozygote; D006801:Humans; D008297:Male; D008661:Metabolism, Inborn Errors / Q000201:enzymology / Q000235:genetics*; D008744:Methylamines / Q000652:urine*; D010105:Oxygenases / Q000235:genetics*; D016133:Polymerase Chain Reaction
D017931:DNA Primers; D008744:Methylamines; D010105:Oxygenases; C020066:dimethylaniline monooxygenase (N-oxide forming); C023336:trimethylamine